Kevin V. Morris

11.4k total citations · 5 hit papers
131 papers, 8.7k citations indexed

About

Kevin V. Morris is a scholar working on Molecular Biology, Cancer Research and Virology. According to data from OpenAlex, Kevin V. Morris has authored 131 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Molecular Biology, 52 papers in Cancer Research and 22 papers in Virology. Recurrent topics in Kevin V. Morris's work include RNA modifications and cancer (47 papers), Cancer-related molecular mechanisms research (44 papers) and RNA Research and Splicing (43 papers). Kevin V. Morris is often cited by papers focused on RNA modifications and cancer (47 papers), Cancer-related molecular mechanisms research (44 papers) and RNA Research and Splicing (43 papers). Kevin V. Morris collaborates with scholars based in United States, Australia and South Africa. Kevin V. Morris's co-authors include John S. Mattick, Marc S. Weinberg, Peter G. Hawkins, John J. Rossi, Per Johnsson, David J. Looney, Dan Grandér, Wan Chan, Steven E. Jacobsen and Daniel H. Kim and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kevin V. Morris

130 papers receiving 8.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The rise of regulatory RNA

2014 979 citations Kevin V. Morris, John S. Mattick Nature Reviews Genetics profile →
Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells

2004 729 citations Kevin V. Morris, Wan Chan et al. Science profile →
Evolutionary conservation of long non-coding RNAs; sequence, structure, function

2013 536 citations Kevin V. Morris et al. profile →
Extracellular vesicles: The next generation in gene therapy delivery

2023 114 citations Kevin V. Morris et al. profile →
Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles

2024 69 citations Kevin V. Morris et al. profile →

Peers

Countries citing papers authored by Kevin V. Morris

Since Specialization

Citations

This map shows the geographic impact of Kevin V. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin V. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin V. Morris more than expected).

Fields of papers citing papers by Kevin V. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin V. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin V. Morris. The network helps show where Kevin V. Morris may publish in the future.

Co-authorship network of co-authors of Kevin V. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin V. Morris. A scholar is included among the top collaborators of Kevin V. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin V. Morris. Kevin V. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation 2025 ·Drug Delivery and Translational Research ·Adi Idris, (unknown), Wenqing Gao, Aroon Supramaniam, Yaman Tayyar, Nicholas P. West, Gabrielle Kelly, Dhruba Acharya, Nigel A.J. McMillan, Kevin V. Morris	1
2	Current State of Therapeutics for HTLV-1 2024 ·Viruses ·(unknown), (unknown), Marcel Doerflinger, Kevin V. Morris, (unknown), Damian F. J. Purcell, Anthony D. Kelleher, Chantelle Ahlenstiel	4
3	An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity. 2024 ·Antiviral Research ·Adi Idris, Aroon Supramaniam, Yaman Tayyar, Gabrielle Kelly, Nigel A.J. McMillan, Kevin V. Morris	11
4	Targeted zinc-finger repressors to the oncogenic HBZ gene inhibit adult T-cell leukemia (ATL) proliferation 2023 ·NAR Cancer ·Tristan Scott, (unknown), Roslyn M. Ray, Kevin V. Morris	2
5	Evaluation of the Elements of Short Hairpin RNAs in Developing shRNA-Containing CAR T Cells 2023 ·Cancers ·Ryan Urak, (unknown), (unknown), Nicole Grepo, Lior Goldberg, (unknown), (unknown), (unknown), (unknown), Tristan Scott, Kevin V. Morris, Stephen J. Forman, Xiuli Wang	2
6	Nuclear microRNA-466c regulates Vegfa expression in response to hypoxia 2022 ·PLoS ONE ·(unknown), (unknown), (unknown), Petri I. Mäkinen, Minna U. Kaikkonen, Marc S. Weinberg, Kevin V. Morris, Paula Korhonen, Tarja Malm, Seppo Ylä‐Herttuala, Thomas C. Roberts, Mikko P. Turunen, (unknown)	12
7	A role for a novel natural antisense-BDNF in the maintenance of nicotine-seeking 2022 ·SHILAP Revista de lepidopterología ·Neil A. Youngson, (unknown), (unknown), (unknown), Nathan M. Holmes, (unknown), Paul D. Waters, Kevin V. Morris, Kelly J. Clemens	2
8	Exosome-mediated stable epigenetic repression of HIV-1 2021 ·Nature Communications ·(unknown), Roslyn M. Ray, (unknown), (unknown), Nicole Grepo, Tristan Scott, John Burnett, Kevin V. Morris	61
9	Development of a Facile Approach for Generating Chemically Modified CRISPR/Cas9 RNA 2020 ·Molecular Therapy — Nucleic Acids ·Tristan Scott, (unknown), Kevin V. Morris	6
10	Persistent histone modifications at the BDNF and Cdk‐5 promoters following extinction of nicotine‐seeking in rats 2017 ·Genes Brain & Behavior ·(unknown), Danay Baker‐Andresen, Vikram S. Ratnu, (unknown), Kevin V. Morris, Timothy W. Bredy, Neil A. Youngson, Kelly J. Clemens	14
11	The rise of regulatory RNA breakdown → 2014 ·Nature Reviews Genetics ·Kevin V. Morris, John S. Mattick	979
12	Long antisense non-coding RNAs and the epigenetic regulation of gene expression 2013 ·BioMolecular Concepts ·Nadia Vadaie, Kevin V. Morris	39
13	Non-coding RNAs and epigenetic regulation of gene expression : drivers of natural selection 2012 ·Kevin V. Morris	19
14	The emerging role of RNA in the regulation of gene transcription in human cells 2011 ·Seminars in Cell and Developmental Biology ·Kevin V. Morris	31
15	Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells 2009 ·Epigenetics ·Kevin V. Morris	88
16	RNA and the regulation of gene expression : a hidden layer of complexity 2008 ·Kevin V. Morris	34
17	Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells 2007 ·Proceedings of the National Academy of Sciences ·Han Jiang, Daniel H. Kim, Kevin V. Morris	221
18	Are Viral-Encoded MicroRNAs Mediating Latent HIV-1 Infection? 2006 ·DNA and Cell Biology ·Marc S. Weinberg, Kevin V. Morris	33
19	siRNA Induced Transcriptional Gene Silencing in Mammalian Cells 2005 ·Cell Cycle ·Hiroaki Kawasaki, (unknown), Kevin V. Morris	45
20	Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells breakdown → 2004 ·Science ·Kevin V. Morris, Wan Chan, Steven E. Jacobsen, David J. Looney	729

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact